What is Muna Therapeutics?
Muna Therapeutics operates at the intersection of advanced neuroscience and drug development. The company is dedicated to identifying and modulating the biological pathways that drive neurodegenerative decline. By targeting the root causes of cognitive and motor impairment, Muna Therapeutics seeks to move beyond symptomatic treatment toward disease-modifying therapies. Its research focus encompasses a broad spectrum of disorders that impact memory, language, and personality, positioning the firm as a critical player in the global effort to combat age-related neurological conditions.
How much funding has Muna Therapeutics raised?
Muna Therapeutics has raised a total of $73M across 1 funding round:
Series A
$73M
Series A (2021): $73M with participation from Sofinnova Partners, Novo Holdings, LSP Dementia Fund, and DROIA Ventures
Key Investors in Muna Therapeutics
Sofinnova Partners
A leading European venture capital firm in life sciences, specializing in healthcare and sustainability with a focus on building transformative innovations from seed to later-stage.
Novo Holdings
A Danish private limited liability company wholly owned by the Novo Nordisk Foundation, focused on long-term investments in life science companies.
DROIA Ventures
A specialized venture capital firm that invests in early-stage and growth-stage companies developing breakthrough therapies for oncology and rare diseases.
What's next for Muna Therapeutics?
With the successful closure of this major enterprise-level funding, Muna Therapeutics is well-positioned to advance its lead candidates through the rigorous stages of preclinical and clinical testing. The strategic roadmap involves deepening its internal R&D capabilities while potentially exploring collaborative partnerships to expedite the commercialization of its therapeutic assets. As the company scales, the focus will remain on maintaining scientific rigor and achieving key milestones that demonstrate the efficacy of its neuro-protective approach in human populations, ultimately aiming to provide life-altering solutions for millions of patients worldwide.
See full Muna Therapeutics company page
